echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > The Safety of 3-Pyridazinecarboxamide,1,6-dihydro-6-oxo-(6CI,7CI,9CI)

    The Safety of 3-Pyridazinecarboxamide,1,6-dihydro-6-oxo-(6CI,7CI,9CI)

    • Last Update: 2023-05-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    3-Pyridazinecarboxamide, also known as 3-Pyridinecarboxamide or 3-Pyridylcarboxamide, is a synthetic organic compound that is widely used in the chemical industry.
    It is a derivative of pyridine, which is a basic organic nitrogen compound with a distinctive unpleasant smell.
    Pyridine and its derivatives are used in a variety of applications, including as precursors to other chemicals, as solvents, and as reagents in chemical reactions.


    One of the key uses of 3-Pyridazinecarboxamide is as a precursor to other chemicals.
    For example, it can be used as a starting material to synthesize other organic compounds, such as pharmaceuticals, dyes, and pigments.
    It is also used as a solvent in the manufacture of certain types of adhesives and coatings.
    In addition, it has applications as a reagent in chemical reactions, such as in the production of polymers and other synthetic materials.


    Despite its widespread use in the chemical industry, 3-Pyridazinecarboxamide is known to be a potentially hazardous chemical.
    It is classified as a Category 2 carcinogen according to the International Agency for Research on Cancer (IARC), which means that it is possibly carcinogenic to humans.
    Animal studies have suggested that exposure to high levels of 3-Pyridazinecarboxamide may increase the risk of cancer, although the evidence is not strong enough to conclusively prove that the chemical causes cancer in humans.


    In addition to its potential cancer-causing properties, 3-Pyridazinecarboxamide is also known to be toxic to humans and other living organisms.
    It can cause a range of adverse health effects, including respiratory problems, skin irritation, and neurological effects.
    Prolonged exposure to high levels of the chemical can also cause damage to the liver and kidneys.


    To minimize the risks associated with 3-Pyridazinecarboxamide, it is important to handle the chemical with care and to take appropriate safety precautions.
    This may include wearing protective clothing, such as gloves and goggles, and working in a well-ventilated area.
    It is also important to store the chemical in a secure location and to dispose of it properly, in accordance with local regulations and guidelines.


    In conclusion, 3-Pyridazinecarboxamide is a useful chemical in the production of a range of other compounds and materials, but it is also known to be potentially hazardous.
    It is classified as a Category 2 carcinogen and is toxic to humans and other living organisms.
    To minimize the risks associated with this chemical, it is important to handle it with care and to take appropriate safety precautions.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.